These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 28003009)

  • 1. Hot Topics in Dry AMD.
    Narayanan R; Kuppermann BD
    Curr Pharm Des; 2017; 23(4):542-546. PubMed ID: 28003009
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exacerbation of choroidal and retinal pigment epithelial atrophy after anti-vascular endothelial growth factor treatment in neovascular age-related macular degeneration.
    Young M; Chui L; Fallah N; Or C; Merkur AB; Kirker AW; Albiani DA; Forooghian F
    Retina; 2014 Jul; 34(7):1308-15. PubMed ID: 24451923
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dry age-related macular degeneration: recent progress of therapeutic approaches.
    Kuno N; Fujii S
    Curr Mol Pharmacol; 2011 Nov; 4(3):196-232. PubMed ID: 21545354
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Macular atrophy in patients with long-term anti-VEGF treatment for neovascular age-related macular degeneration.
    Munk MR; Ceklic L; Ebneter A; Huf W; Wolf S; Zinkernagel MS
    Acta Ophthalmol; 2016 Dec; 94(8):e757-e764. PubMed ID: 27417506
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Age-related macular degeneration therapy: a review.
    Ammar MJ; Hsu J; Chiang A; Ho AC; Regillo CD
    Curr Opin Ophthalmol; 2020 May; 31(3):215-221. PubMed ID: 32205470
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hot Topics in Pharmacotherapy for Neovascular Age-Related Macular Degeneration.
    Falavarjani KG; Sadda SR
    Curr Pharm Des; 2017; 23(4):535-541. PubMed ID: 27981904
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optical Coherence Tomography Features Preceding the Onset of Advanced Age-Related Macular Degeneration.
    Ferrara D; Silver RE; Louzada RN; Novais EA; Collins GK; Seddon JM
    Invest Ophthalmol Vis Sci; 2017 Jul; 58(9):3519-3529. PubMed ID: 28715590
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intraocular growth factors and cytokines in patients with dry and neovascular age-related macular degeneration.
    Muether PS; Neuhann I; Buhl C; Hermann MM; Kirchhof B; Fauser S
    Retina; 2013 Oct; 33(9):1809-14. PubMed ID: 23492946
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peripheral Retinal Changes Associated with Age-Related Macular Degeneration in the Age-Related Eye Disease Study 2: Age-Related Eye Disease Study 2 Report Number 12 by the Age-Related Eye Disease Study 2 Optos PEripheral RetinA (OPERA) Study Research Group.
    ; Domalpally A; Clemons TE; Danis RP; Sadda SR; Cukras CA; Toth CA; Friberg TR; Chew EY
    Ophthalmology; 2017 Apr; 124(4):479-487. PubMed ID: 28089680
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PERIPAPILLARY RETINAL PIGMENT EPITHELIUM CHANGES IN AGE-RELATED MACULAR DEGENERATION.
    Cohen SY; Dubois L; Grenet T; Nghiem-Buffet S; Jung C; Fajnkuchen F; Delahaye-Mazza C; Quentel G; Tadayoni R
    Retina; 2016 Mar; 36(3):458-64. PubMed ID: 26267678
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retrospective hospital-based analysis of age-related macular degeneration patterns in India: 5-year follow-up.
    Sudhalkar A; Sethi V; Gogte P; Bondalapati S; Khodani M; Chhablani JK
    Indian J Ophthalmol; 2015 Dec; 63(12):899-904. PubMed ID: 26862094
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatments for dry age-related macular degeneration: therapeutic avenues, clinical trials and future directions.
    Cabral de Guimaraes TA; Daich Varela M; Georgiou M; Michaelides M
    Br J Ophthalmol; 2022 Mar; 106(3):297-304. PubMed ID: 33741584
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hot Topics in Pharmacogenetics of Age-Related Macular Degeneration.
    Schwartz SG; Brantley MA; Kovach JL; Grzybowski A
    Curr Pharm Des; 2017; 23(4):547-550. PubMed ID: 27928964
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dry Age-Related Macular Degeneration Pharmacology.
    Wright CB; Ambati J
    Handb Exp Pharmacol; 2017; 242():321-336. PubMed ID: 27900609
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Forecasting age-related macular degeneration through the year 2050: the potential impact of new treatments.
    Rein DB; Wittenborn JS; Zhang X; Honeycutt AA; Lesesne SB; Saaddine J;
    Arch Ophthalmol; 2009 Apr; 127(4):533-40. PubMed ID: 19365036
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progression of retinal pigment epithelial atrophy in antiangiogenic therapy of neovascular age-related macular degeneration.
    Schütze C; Wedl M; Baumann B; Pircher M; Hitzenberger CK; Schmidt-Erfurth U
    Am J Ophthalmol; 2015 Jun; 159(6):1100-1114.e1. PubMed ID: 25769245
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Change of retinal pigment epithelial atrophy after anti-vascular endothelial growth factor treatment in exudative age-related macular degeneration.
    Kim M; Kim ES; Seo KH; Yu SY; Kwak HW
    Indian J Ophthalmol; 2016 Jun; 64(6):427-33. PubMed ID: 27488150
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Investigational drugs in clinical trials for macular degeneration.
    Tolentino MJ; Tolentino AJ
    Expert Opin Investig Drugs; 2022 Oct; 31(10):1067-1085. PubMed ID: 35962560
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outer retinal corrugations in age-related macular degeneration.
    Ooto S; Vongkulsiri S; Sato T; Suzuki M; Curcio CA; Spaide RF
    JAMA Ophthalmol; 2014 Jul; 132(7):806-13. PubMed ID: 24801396
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Age-related Macular Degeneration in the Japanese].
    Yoshimura N
    Nippon Ganka Gakkai Zasshi; 2016 Mar; 120(3):163-88; discussion 189. PubMed ID: 27164756
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.